News

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) ...
A study presented at ESCMID Global 2025 has demonstrated that an AI-powered lung ultrasound outperforms human experts by 9% ...
In a Johns Hopkins Children’s Center study, the addition of navitoclax to the standard TB treatment significantly increased ...
A pioneering study presented today at ESCMID Global 2025 has demonstrated that an AI-powered lung ultrasound outperforms human experts by 9% in diagnosing pulmonary tuberculosis (TB).
A point-of-care lung ultrasound system connected to a smartphone combined with a suite of deep learning models outperformed ...
Findings presented at ESCMID Global 2025 highlight the potential of AI-enhanced ultrasound as a frontline diagnostic tool for ...
A study has shown that an AI-powered lung ultrasound outperforms human experts by 9% in diagnosing pulmonary tuberculosis ...
After exclusions, 504 patients were included, with 192 (38%) confirmed to have pulmonary TB. Among the study population, 15% were HIV-positive and 13% had a history of TB. A standardised 14-point ...
This can lower the chances of infection. Tuberculosis can cause severe damage to the lungs, leaving patients with health issues, such as shortness of breath, for years after the infection is cured ...
Tuberculosis (TB) cases rose 13 per cent in England last year, with increases among both immigrants and people born in the UK ...